T. Laurencin Cato's Insider Trades & SAST Disclosures
T. Laurencin Cato's most recent trade in Alkermes plc was a trade of 8,013 Restricted Stock Unit Award done . Disclosure was reported to the exchange on May 31, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern T. Laurencin Cato.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Alkermes plc | Cato T. Laurencin | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 May 2025 | 8,013 | 0 | - | - | Restricted Stock Unit Award | |
| Alkermes plc | Cato T. Laurencin | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 May 2025 | 8,013 | 31,026 (0%) | 0% | - | Ordinary Shares | |
| Alkermes plc | Cato T. Laurencin | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 30.61 per share. | 31 May 2025 | 1,924 | 29,102 (0%) | 0% | 30.6 | 58,894 | Ordinary Shares |
| Alkermes plc | Cato T. Laurencin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2025 | 13,474 | 13,474 | - | - | Non Qualified Stock Option (Right to Buy) | |
| Alkermes plc | Cato T. Laurencin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2025 | 6,142 | 6,142 | - | - | Restricted Stock Unit Award | |
| Alkermes plc | Cato T. Laurencin | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Dec 2024 | 4,163 | 23,971 (0%) | 0% | - | Ordinary Shares | |
| Alkermes plc | Cato T. Laurencin | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Dec 2024 | 4,163 | 0 | - | - | Restricted Stock Unit Award | |
| Alkermes plc | Cato T. Laurencin | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Dec 2024 | 2,691 | 16,142 | - | - | Non Qualified Stock Option (Right to Buy) | |
| Alkermes plc | Cato T. Laurencin | Director | Sale of securities on an exchange or to another person at price $ 31.85 per share. | 08 Dec 2024 | 2,691 | 23,013 (0%) | 0% | 31.8 | 85,708 | Ordinary Shares |
| Alkermes plc | Cato T. Laurencin | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 22.52 per share. | 08 Dec 2024 | 2,691 | 25,704 (0%) | 0% | 22.5 | 60,601 | Ordinary Shares |
| Alkermes plc | Cato T. Laurencin | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 31.46 per share. | 08 Dec 2024 | 958 | 23,013 (0%) | 0% | 31.5 | 30,139 | Ordinary Shares |
| Alkermes plc | Cato T. Laurencin | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Jun 2024 | 6,104 | 0 | - | - | Restricted Stock Unit Award | |
| Alkermes plc | Cato T. Laurencin | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Jun 2024 | 6,104 | 21,273 (0%) | 0% | - | Ordinary Shares | |
| Alkermes plc | Cato T. Laurencin | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 24.10 per share. | 29 Jun 2024 | 1,465 | 19,808 (0%) | 0% | 24.1 | 35,307 | Ordinary Shares |
| Mimedx Group Inc | Cato T. Laurencin | Director | Grant, award, or other acquisition of securities at price $ 7.26 per share. | 05 Jun 2024 | 23,190 | 153,314 (0%) | 0% | 7.3 | 168,359 | Common Stock |
| Alkermes plc | Cato T. Laurencin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 May 2024 | 17,492 | 17,492 | - | - | Non Qualified Stock Option (Right to Buy) | |
| Alkermes plc | Cato T. Laurencin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 May 2024 | 8,013 | 8,013 | - | - | Restricted Stock Unit Award | |
| Alkermes plc | Cato T. Laurencin | Director | Sale of securities on an exchange or to another person at price $ 31.85 per share. | 15 Feb 2024 | 2,690 | 15,169 (0%) | 0% | 31.9 | 85,677 | Ordinary Shares |
| Alkermes plc | Laurencin Cato T. | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 22.52 per share. | 15 Feb 2024 | 2,690 | 17,859 (0%) | 0% | 22.5 | 60,579 | Ordinary Shares |
| Alkermes plc | Laurencin T. Cato | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2024 | 2,690 | 18,833 | - | - | Non Qualified Stock Option (Right to Buy) | |
| Alkermes plc | Cato Laurencin T. | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Dec 2023 | 4,163 | 4,163 | - | - | Restricted Stock Unit Award | |
| Alkermes plc | Cato T. Laurencin | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Dec 2023 | 4,163 | 16,169 (0%) | 0% | - | Ordinary Shares | |
| Alkermes plc | Laurencin Cato T. | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 25.86 per share. | 08 Dec 2023 | 1,000 | 15,169 (0%) | 0% | 25.9 | 25,860 | Ordinary Shares |
| Alkermes plc | T. Laurencin Cato | Director | Other type of transaction at price $ 0.00 per share. | 08 Dec 2023 | 422 | 21,523 | - | - | Non Qualified Stock Option (Right to Buy) | |
| Alkermes plc | Laurencin T. Cato | Director | Other type of transaction at price $ 0.00 per share. | 08 Dec 2023 | 254 | 12,986 | - | - | Non Qualified Stock Option (Right to Buy) | |
| Alkermes plc | T. Laurencin Cato | Director | Other type of transaction at price $ 0.00 per share. | 08 Dec 2023 | 231 | 11,785 | - | - | Non Qualified Stock Option (Right to Buy) | |
| Alkermes plc | Cato Laurencin T. | Director | Other type of transaction at price $ 0.00 per share. | 08 Dec 2023 | 163 | 8,326 | - | - | Restricted Stock Unit Award | |
| Alkermes plc | T. Cato Laurencin | Director | Other type of transaction at price $ 0.00 per share. | 08 Dec 2023 | 119 | 6,104 | - | - | Restricted Stock Unit Award | |
| Alkermes plc | T. Cato Laurencin | Director | Other type of transaction at price $ 0.00 per share. | 08 Dec 2023 | 112 | 5,712 | - | - | Non Qualified Stock Option (Right to Buy) | |
| Alkermes plc | Cato T. Laurencin | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Jul 2023 | 5,957 | 0 | - | - | Restricted Stock Unit Award | |
| Alkermes plc | Cato T. Laurencin | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Jul 2023 | 5,957 | 13,436 (0%) | 0% | - | Ordinary Shares | |
| Alkermes plc | Cato T. Laurencin | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 29.88 per share. | 07 Jul 2023 | 1,430 | 12,006 (0%) | 0% | 29.9 | 42,728 | Ordinary Shares |
| Alkermes plc | Cato T. Laurencin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jun 2023 | 12,732 | 12,732 | - | - | Non Qualified Stock Option (Right to Buy) | |
| Alkermes plc | Cato T. Laurencin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jun 2023 | 5,985 | 5,985 | - | - | Restricted Stock Unit Award | |
| Mimedx Group Inc | Cato T. Laurencin | Director | Grant, award, or other acquisition of securities at price $ 4.95 per share. | 13 Jun 2023 | 35,354 | 130,124 (0%) | 0% | 4.9 | 175,002 | Common Stock |
| Alkermes plc | Cato T. Laurencin | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Jun 2023 | 2,638 | 21,101 | - | - | Non Qualified Stock Option (Right to Buy) | |
| Alkermes plc | Cato T. Laurencin | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 22.97 per share. | 08 Jun 2023 | 2,638 | 10,117 (0%) | 0% | 23.0 | 60,595 | Ordinary Shares |
| Alkermes plc | Cato T. Laurencin | Director | Sale of securities on an exchange or to another person at price $ 31.85 per share. | 08 Jun 2023 | 2,638 | 7,479 (0%) | 0% | 31.8 | 84,020 | Ordinary Shares |
| Alkermes plc | Cato T. Laurencin | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Jun 2023 | 2,800 | 5,600 | - | - | Non Qualified Stock Option (Right to Buy) | |
| Alkermes plc | Cato T. Laurencin | Director | Sale of securities on an exchange or to another person at price $ 31.50 per share. | 07 Jun 2023 | 2,800 | 7,479 (0%) | 0% | 31.5 | 88,200 | Ordinary Shares |
| Alkermes plc | Cato T. Laurencin | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 22.97 per share. | 07 Jun 2023 | 2,800 | 10,279 (0%) | 0% | 23.0 | 64,316 | Ordinary Shares |
| Alkermes plc | Cato T. Laurencin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jul 2022 | 11,554 | 11,554 | - | - | Non Qualified Stock Option (Right to Buy) | |
| Alkermes plc | Cato T. Laurencin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jul 2022 | 5,957 | 5,957 | - | - | Restricted Stock Unit Award | |
| Mimedx Group Inc | Cato T. Laurencin | Director | Grant, award, or other acquisition of securities at price $ 3.96 per share. | 07 Jun 2022 | 44,191 | 94,770 (0%) | 0% | 4.0 | 174,996 | Common Stock |
| Mimedx Group Inc | Cato T. Laurencin | Director | Grant, award, or other acquisition of securities at price $ 10.26 per share. | 27 May 2021 | 17,056 | 50,579 (0%) | 0% | 10.3 | 174,995 | Common Stock |
| Mimedx Group Inc | Cato T. Laurencin | Director | Grant, award, or other acquisition of securities at price $ 7.83 per share. | 16 Dec 2020 | 22,349 | 22,349 (0%) | 0% | 7.8 | 174,993 | Common Stock |
| Mimedx Group Inc | Cato T. Laurencin | Director | Grant, award, or other acquisition of securities at price $ 7.83 per share. | 16 Dec 2020 | 11,174 | 33,523 (0%) | 0% | 7.8 | 87,492 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges